Labor Care Guide Application (LCG)

June 29, 2026 updated by: Ain Shams University

Labor Care Guide Application in Ain Shams University Maternity Hospital: A Randomized Controlled Trial

Application of the WHO Labor Care Guide in Ain Shams university Maternity hospital demonstrates high healthcare provider acceptability and improves labor progression, increases vaginal delivery rates, and reduces selected maternal complications without adversely affecting neonatal outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Labor Care Guide (LCG) is a tool developed by the World Health Organization (WHO) to support evidence-based, woman-centered intrapartum care and improve labor monitoring. It was introduced as an alternative to the traditional partograph, aiming to facilitate timely clinical decision-making and enhance the quality of maternity care.

This randomized controlled trial was conducted at Ain Shams University Maternity Hospital to evaluate the effect of the WHO Labor Care Guide on maternal and neonatal outcomes among women undergoing vaginal delivery. Eligible pregnant women were randomly assigned to one of two groups: a study group monitored using the WHO Labor Care Guide and a control group monitored using the modified WHO partograph.

Participants underwent routine obstetric assessment and monitoring throughout labor according to the allocated monitoring tool. Maternal outcomes assessed included labor progression, mode of delivery, and intrapartum and postpartum complications. Neonatal outcomes included neonatal well-being, need for neonatal intensive care admission, and neonatal complications. Healthcare provider satisfaction with the labor monitoring tool was also evaluated.

The study aimed to compare the effectiveness of the WHO Labor Care Guide with the modified WHO partograph in supporting labor management and improving maternal and neonatal care.

Study Type

Interventional

Enrollment (Actual)

350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Ain Shams University Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Pregnant woman who will undergo vaginal delivery at Ain Shams University Maternity Hospital with gestational age above or equal 37 weeks
  2. Vertex presentation .
  3. Women with estimated fetal weight 2.5 till 4 kg

Exclusion Criteria::

  1. Placenta previa
  2. Placenta previa accreta
  3. Macrosomic baby above 4 kg in diabetic women and above 4.5 kg in non diabetic women
  4. Placenta abruption complicated by non reassuring CTG or life threatening bleeding
  5. Cord prolapse
  6. Vasa previa
  7. Primary active genital herpes simplex
  8. Patient with anemia which may lead to atonic uterus and prolonged labor.
  9. Women with previously scarred uterus due to risk of ruptured uterus and postpartum hemorrhage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Labor care guide
Intervensional study
labor monitoring tool
No Intervention: partogrph
no intervension

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare Provider Satisfaction as Measured by the Provider Satisfaction Questionnaire (PSQ)
Time Frame: assessed at 6 months
Measured using a 5-point Likert scale. Range: 1-5. Higher scores indicate greater satisfaction.
assessed at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mode of delivery
Time Frame: At delivery
The percentage of participants undergoing different modes of delivery (e.g., normal vaginal delivery, operative vaginal delivery, or cesarean section)
At delivery
Duration of active labor
Time Frame: At delivery
The total duration of the active phase of labor, measured in hours.
At delivery
Incidence of maternal complications
Time Frame: assessed at 6 weeks postpartum
The percentage of mothers who experience any postpartum or intrapartum complications (e.g., postpartum hemorrhage, infection).
assessed at 6 weeks postpartum
Incidence of neonatal complications
Time Frame: At delivery
The percentage of newborns who experience neonatal complications (e.g., respiratory distress, hypoglycemia).
At delivery
Duration of hospital stay
Time Frame: from birth until hospital discharge average 2 to 3 days
The total number of days the mother and/or neonate remained hospitalized from admission to discharge.
from birth until hospital discharge average 2 to 3 days
Neonatal Outcomes via Apgar Score and NICU Admission
Time Frame: from birth until hospital discharge average 2 to 3 days
Neonatal well-being will be assessed using the Apgar score at 5 minutes (ranging from 0 to 10, where higher scores indicate better neonatal health) and the rate of admission to the Neonatal Intensive Care Unit (NICU).
from birth until hospital discharge average 2 to 3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Actual)

August 1, 2025

Study Completion (Actual)

August 1, 2025

Study Registration Dates

First Submitted

June 10, 2026

First Submitted That Met QC Criteria

June 29, 2026

First Posted (Actual)

July 7, 2026

Study Record Updates

Last Update Posted (Actual)

July 7, 2026

Last Update Submitted That Met QC Criteria

June 29, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • MS459

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Comfort

Clinical Trials on labor care guide

3
Subscribe